Key result
CFOA-based ECG pre-amplifier achieves ~75 dB common-mode rejection ratio for effective noise removal.
Why the study?
The study was conducted to design a robust front-end amplifier circuit to denoise ECG signals by removing baseline wander, powerline interference, and motion artifacts.
A novel CFOA-based ECG front-end amplifier demonstrates high common-mode rejection and mid-band gain, offering a robust solution for noise removal in wearable ECG monitoring.
Offers a hardware-level approach to improve ECG signal fidelity; leaves open clinical validation of this prototype in.
This paper introduces an electrocardiogram (ECG) noise removal front-end amplifier circuit based on a current-feedback operational amplifier (CFOA) that uses the current feedback to detect error signals and control the output. This ECG circuit focuses on denoising the ECG noise to accentuate the ECG electrical signals from the heart. Noises in ECG refer to baseline wander (BW), powerline interference (PLI) and motion artifacts. We proposed a CFOA-based ECG pre-amplifier using the AD844 commercial operational amplifier built inside with a positive second-generation current conveyor (CCII+) and a voltage follower circuit. This work introduces an ECG noise removal front-end amplifier based on a CFOA. The primary innovation lies in the balancing instrumentation amplifier architecture that utilizes the high-speed and robust properties of the AD844 commercial operational amplifier to achieve superior noise rejection. To protect against high-frequency interference, we introduce a novel cascaded low-pass filter (LPF) stage that ensures a sharper cut-off compared to traditional single-stage designs. Experimental results validate the design’s effectiveness, achieving a high common-mode rejection ratio (CMRR) of 75.4 dB and a mid-band gain of 46.5 dB. These performance metrics, combined with the circuit’s ability to eliminate BW and PLI, confirm its robust suitability for high-fidelity wearable ECG monitoring.
No takes yet. Share an insight, caveat, or question.
Sitjongsataporn et al. (2026) studied ECG noise removal. CFOA-based ECG pre-amplifier using AD844 was evaluated on Common-mode rejection ratio (CMRR) and mid-band gain. A CFOA-based ECG pre-amplifier using the AD844 operational amplifier achieved a high common-mode rejection ratio of 75.4 dB and a mid-band gain of 46.5 dB for ECG noise removal.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: